USAID has just awarded $160 million to the United States Pharmacopeia (USP) for a cooperative agreement to regulate the pharmaceutical landscape in Africa. U.S. taxpayers are now funding a U.S. State Department approved plan developed so our government can help big pharma pimps. Here’s a look inside USP and this latest USAID plan.
If you scan the Board of Trustees of the NGO USP you will immediately run into BIG BUSINESS shining like the sleazy glow from some red-light district brothel in Paris or New Orleans. Aventis, Bristol-Myers Squibb Company, India’s Laurus Labs, Eli Lilly & Company, Pfizer, Pharmacia, Upjohn, France’s Sanofi, and all the likely suspects are proudly listed in plain sight. The agri-giants are there too, smiling out at you like comic book villains from DC or Marvel. There’s FSG consulting executives proud to have been solving the world’s problems since the Soviet Union fell. FDA Chief Scientists are listed, and so are Washington regulatory specialists (and lobbyists) representing firms like Greenleaf Health Inc.
Ronald T. Piervincenzi, Ph.D., the CEO of USP could serve as the poster boy for big pharma and big Agra businesses. Ronald’s major in college way biomedical engineering. Ronald now sets the standards for most every medication sold in the United States. He got his start at Hofstra University on Long Island and from visits to the Naval Research Laboratory in Washington DC. He went to Duke University and got a “magical” full-time position with McKinsey & Company. You can read the rest of “Ron Piervincenzi: A Series of Fortunate Events” here.
You can see Ron here in Nigeria alongside USAID in Nigeria when the National Agency for Food and Drug Administration and Control (NAFDAC) Kaduna laboratory was accreditated in 2017. At first glance, USP and USAID efforts appear viable, straightforward, and even altruistic and noble. This is from the press release on the most recent USAID-USP effort in Africa:
“To achieve the goal of PQM+, USP and its partners will work to strengthen governance and regulatory structures, optimize the allocation and use of resources, improve the supply of quality-assured medical products….”
USP and USAID capitalize on the problems of bad or illegitimate drugs administered for tough diseases like malaria.
» Lees verder
American taxpayers are now paying the salaries and expenses of dozens of Venezuelan opposition figures who have created a “shadow government” inside Venezuela and abroad. On October 8, USAID signed a bilateral agreement with the faction of the Venezuelan opposition led by National Assembly president Juan Guaidó (whom the Trump administration recognizes as the “interim president” of Venezuela) that includes $98 million in assistance for Venezuelans. A memo obtained by the L.A. Times reveals that USAID is diverting $41.9 million from aid for Central America and instead sending it “to Guaidó and his faction… to pay for their salaries, airfare, ‘good governance’ training, propaganda, technical assistance for holding elections and other ‘democracy-building’ projects.”
Elliott Abrams, the White House’s special envoy to Venezuela, said in an interview that the Trump administration wants to “pay for embassies, ambassadors [and] a National Assembly office in Caracas” for Guaidó’s team. At the signing of the USAID agreement, Carlos Vecchio, Mr. Guaidó’s representative in Washington, praised the agency for helping to “enhance our capabilities… in increasing our foreign service,” confirming that funds are going to the Guaidó team. With this public admission of financing, there is now no denying that the coup is orchestrated from Washington and that whatever authority Mr. Guaidó may have is only a function of his serving as a U.S. proxy.
To date, no information has been made public as to whose salaries are being paid and how much they are being paid. What we do know is that the hard-earned dollars of American citizens are lining the pockets of Venezuelan politicians who have demanded an increasingly harder line against the Maduro government. This harder line includes brutal economic sanctions that amount to the collective punishment of ordinary Venezuelans and have led to the death of at least 40,000 people.
Mr. Guaidó has been taking the Trump administration for a ride, and now he and his followers are cashing in. Nearly nine months after his coup began, he is no closer to being in power than he was when he swore himself into office on a street corner in Caracas. There has been no increase in the number of countries that support the coup (54 have followed the U.S.
» Lees verder